NGB
gene geneOn this page
Summary
NGB (neuroglobin, HGNC:14077) is a protein-coding gene on chromosome 14q24.3, encoding Neuroglobin (Q9NPG2). Monomeric globin with a bis-histidyl six-coordinate heme-iron atom through which it can bind dioxygen, carbon monoxide and nitric oxide.
This gene encodes an oxygen-binding protein that is distantly related to members of the globin gene family. It is highly conserved among other vertebrates. It is expressed in the central and peripheral nervous system where it may be involved in increasing oxygen availability and providing protection under hypoxic/ischemic conditions.
Source: NCBI Gene 58157 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_021257
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14077 |
| Approved symbol | NGB |
| Name | neuroglobin |
| Location | 14q24.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000165553 |
| Ensembl biotype | protein_coding |
| OMIM | 605304 |
| Entrez | 58157 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000298352
RefSeq mRNA: 1 — MANE Select: NM_021257
NM_021257
CCDS: CCDS9856
Canonical transcript exons
ENST00000298352 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001094043 | 77265483 | 77266670 |
| ENSE00001094044 | 77268466 | 77268585 |
| ENSE00001094048 | 77269215 | 77269326 |
| ENSE00001202356 | 77270849 | 77271206 |
Expression profiles
Bgee: expression breadth ubiquitous, 110 present calls, max score 87.21.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0736 / max 6.9550, expressed in 45 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144217 | 0.0439 | 23 |
| 144216 | 0.0297 | 21 |
Top tissues by expression
271 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right frontal lobe | UBERON:0002810 | 87.21 | gold quality |
| hypothalamus | UBERON:0001898 | 85.92 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.48 | gold quality |
| endothelial cell | CL:0000115 | 83.84 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 83.58 | gold quality |
| frontal cortex | UBERON:0001870 | 83.51 | gold quality |
| cingulate cortex | UBERON:0003027 | 83.45 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.43 | gold quality |
| prefrontal cortex | UBERON:0000451 | 83.42 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 83.29 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 83.06 | gold quality |
| neocortex | UBERON:0001950 | 82.55 | gold quality |
| primary visual cortex | UBERON:0002436 | 81.11 | gold quality |
| cerebral cortex | UBERON:0000956 | 79.45 | gold quality |
| postcentral gyrus | UBERON:0002581 | 79.06 | gold quality |
| Brodmann (1909) area 23 | UBERON:0013554 | 78.65 | gold quality |
| buccal mucosa cell | CL:0002336 | 78.08 | silver quality |
| middle temporal gyrus | UBERON:0002771 | 77.35 | gold quality |
| secondary oocyte | CL:0000655 | 76.92 | gold quality |
| pituitary gland | UBERON:0000007 | 76.70 | gold quality |
| parietal lobe | UBERON:0001872 | 76.67 | gold quality |
| amygdala | UBERON:0001876 | 76.64 | gold quality |
| forebrain | UBERON:0001890 | 76.30 | gold quality |
| adenohypophysis | UBERON:0002196 | 75.87 | gold quality |
| telencephalon | UBERON:0001893 | 75.70 | gold quality |
| occipital lobe | UBERON:0002021 | 75.43 | gold quality |
| oocyte | CL:0000023 | 74.50 | gold quality |
| temporal lobe | UBERON:0001871 | 74.23 | gold quality |
| brain | UBERON:0000955 | 74.09 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 72.53 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.00 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CREB1, EGR1, HIF1A, NFKB1, NFKB, REL, RELA, SP1, SP3
miRNA regulators (miRDB)
33 targeting NGB, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-512-3P | 99.97 | 67.35 | 1049 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-6721-5P | 99.93 | 68.92 | 2981 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-6817-3P | 99.79 | 68.35 | 2126 |
| HSA-MIR-548AG | 99.77 | 69.25 | 1492 |
| HSA-MIR-548M | 99.70 | 68.87 | 1749 |
| HSA-MIR-548AI | 99.69 | 69.24 | 1494 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-570-5P | 99.69 | 69.24 | 1494 |
| HSA-MIR-10394-5P | 99.65 | 66.83 | 1852 |
| HSA-MIR-1205 | 99.65 | 66.76 | 1826 |
| HSA-MIR-486-3P | 99.51 | 66.82 | 1901 |
| HSA-MIR-1324 | 99.46 | 66.57 | 1302 |
| HSA-MIR-532-3P | 99.34 | 65.76 | 1195 |
| HSA-MIR-4505 | 99.27 | 67.81 | 2678 |
| HSA-MIR-5787 | 99.22 | 67.86 | 2628 |
| HSA-MIR-1286 | 99.09 | 66.23 | 1046 |
| HSA-MIR-661 | 99.09 | 65.94 | 2062 |
| HSA-MIR-6506-5P | 99.04 | 65.66 | 1386 |
| HSA-MIR-1207-3P | 98.99 | 66.22 | 1532 |
| HSA-MIR-1909-5P | 98.94 | 64.01 | 484 |
| HSA-MIR-330-5P | 98.73 | 67.63 | 1788 |
| HSA-MIR-6501-3P | 98.71 | 67.45 | 1480 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-619-5P | 98.57 | 64.97 | 1988 |
| HSA-MIR-5187-5P | 98.54 | 67.94 | 952 |
| HSA-MIR-326 | 98.25 | 66.44 | 1565 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
Literature-anchored findings (GeneRIF, showing 40)
- Full-length cDNA cloning and genomic organization of NGB have been reported. (PMID:11820779)
- Expression is induced by hemin in neural cells (PMID:12239161)
- an examination of the protein’s structure by crystallization and x-ray diffraction (PMID:12351835)
- human Ngb may be a novel oxidative stress-responsive sensor for signal transduction in the brain (PMID:12860983)
- results suggest a novel mechanism for the regulation of oxygen binding; contact with an appropriate electron donor would provoke the release of oxygen. Hence the oxygen affinity would be directly linked to the redox state of the cell. (PMID:14530264)
- His64 and Lys67 comprise a unique distal heme pocket in neuroglobin (PMID:14645216)
- Results are the first to demonstrate an interaction between neuroglobin (Ngb) and cystatin C. Ngb may modulate the intracellular transport (or secretion) of cystatin C to protect against neuronal death under conditions of oxidative stress. (PMID:15122877)
- Analysis of the neuroglobin genomic sequence identifies sequence motifs with similarity to the neuron-restrictive silencer element, possibly explaining a neuron-specific expression of neuroglobin. (PMID:15193759)
- oxygen binding in human neuroglobin and cytoglobin is allosterically regulated and temperature-dependent (PMID:15299006)
- Data show that wild-type human recombinant neuroglobin favors the F8His-Fe2+ -E7His conformation. (PMID:15488767)
- Identification of several residues that are crucial for several residues that are crucial for the Guanine nucleotide dissociation inhibitor activity of human Ngb. (PMID:15723537)
- TAT-Ngb is an efficient fusion protein capable of protecting the human islets in culture from loss of cell mass and function, thus increasing the quality of transplantable islets. (PMID:15808606)
- molecular characterization of human and Drosophila cytoglobulins and neuroglobulins (PMID:15819897)
- analysis of the proximal and distal histidine environment of cytoglobin and neuroglobin (PMID:16201751)
- Sites of interaction between Ngb and Galpha(i). (PMID:17337004)
- ferric-NGB acts not only as scavenger of toxic species, but also as a target of the self-generated reactive species (PMID:17600531)
- protein oxidation promotes stabilization of pentacoordinated species, thus favoring protein to adopt more reactive state & supporting existence of molecular mechanism where O2 is released under hypoxic conditions, suggesting O(2) storage function for Ngb. (PMID:17975837)
- These results clearly show that the GDI activity of human Ngb is tightly correlated with its neuroprotective activity. (PMID:18302932)
- both zebrafish and chimeric ZHHH Ngb can penetrate cell membranes in the absence of Chariot (PMID:18416560)
- A feature of Ngb is its heme hexacoordination in the absence of external ligands, observed both in the ferrous and in the ferric (met) forms. (PMID:18767815)
- Neuroglobin and cytoglobin are colocalized within human retinal neurons and retinal pigment epithelium but not within glial cells. (PMID:19001220)
- A significant association was found between Alzheimer disease risk and a variant in the NGB gene. Data is consistent with a model where women, older individuals and carriers of specific genotypes have lower levels of NGB leading to increased risk for AD. (PMID:19010568)
- Ngb polymorphism 89+104 t had protective effects on large-artery atherosclerosis and small-vessel occlusion in the Southern Chinese Han population (PMID:19087291)
- Structure determination by molecular replacement of neuroglobin at 1.8 A resolution showed the apparent space group was orthorhombic C222(1), but the real space group was monoclinic P2(1), due to twinning. It is a perfect hemihedrally twinned crystal. (PMID:19307722)
- Results demonstrate by immunohistochemical analysis the colocalization of neuroglobin and PrP(c) in the retinal ganglion cell layer. (PMID:19327369)
- neuroglobin transcript and protein are expressed in human glioblastoma cells, and this expression increases in hypoxia in vitro (PMID:19383366)
- The conformational and functional stability of Ngb at acidic pH was analyzed. (PMID:19860834)
- Ischemic stroke increases the expresssion of the neuroprotective protein neuroglobin in brain. (PMID:20075359)
- These data provides an explanation the action of neuroglobin in the protection of nerve cells from unwanted apoptosis. (PMID:20091232)
- The acid-induced denaturation pathway of apo-Ngb can be illustrated from the native state (N), via a partially unfolded state (U(A)) to the molten globule state (MG). (PMID:20227336)
- the haplotype block represented by rs3783988 in neuroglobin appears to influence recovery after severe traumatic brain injury (PMID:20345238)
- Ngb may confer protection against ischemia-reperfusion injury in the brain through its intrinsic antioxidant properties. (PMID:20571522)
- These data favor the hypothesis that the disulfide bond between Cys46 and Cys55 modulates the functioning of human neuroglobin. (PMID:20643048)
- There is a plausible central role for neuroglobin in the control of apoptosis. (PMID:21190290)
- neuroglobin may function as a physiological oxidative stress sensor and a post-translationally redox-regulated nitrite reductase that generates NO under six-to-five-coordinate heme pocket control (PMID:21296891)
- Cimeric Myoglobin has a cell-membrane-penetrating activity similar to zebrafish Ngb. (PMID:21304818)
- Data suggest a potential role of DNA methylation in regulating NGB tissue-specific expression. (PMID:21362510)
- overexpression in non-small cell lung cancer is associated with histological subtype, hypoxia (PMID:21601304)
- This review describes the discovery of neuroglobin over a decade ago, its structure, affinity for oxygen, and its expression in cerebral neurons, all of which suggest it plays a role in providing oxygen to the brain. (PMID:21620833)
- Caenorhabditis elegans globin GLB-26 (expressed from gene T22C1.2) has been studied in comparison with human neuroglobin (Ngb) and cytoglobin (Cygb) for its electron transfer properties (PMID:21674044)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ngb | ENSDARG00000053475 |
| mus_musculus | Ngb | ENSMUSG00000021032 |
| rattus_norvegicus | Ngb | ENSRNOG00000011719 |
Protein
Protein identifiers
Neuroglobin — Q9NPG2 (reviewed: Q9NPG2)
Alternative names: Nitrite reductase
All UniProt accessions (2): A0M8W9, Q9NPG2
UniProt curated annotations — full annotation on UniProt →
Function. Monomeric globin with a bis-histidyl six-coordinate heme-iron atom through which it can bind dioxygen, carbon monoxide and nitric oxide. Could help transport oxygen and increase its availability to the metabolically active neuronal tissues, though its low quantity in tissues as well as its high affinity for dioxygen, which may limit its oxygen-releasing ability, argue against it. The ferrous/deoxygenated form exhibits a nitrite reductase activity and it could produce nitric oxide which in turn inhibits cellular respiration in response to hypoxia. In its ferrous/deoxygenated state, it may also exhibit GDI (Guanine nucleotide Dissociation Inhibitor) activity toward heterotrimeric G-alpha proteins, thereby regulating signal transduction to facilitate neuroprotective responses in the wake of hypoxia and associated oxidative stress.
Subunit / interactions. Monomer. Homodimer and homotetramer; disulfide-linked. Mainly monomeric but also detected as part of homodimers and homotetramers. Interacts with 14-3-3 proteins; regulates the phosphorylation of NGB. Could interact (ferrous form) with G-alpha(i) proteins (GTP-bound form).
Subcellular location. Cytoplasm. Cytosol. Mitochondrion matrix.
Tissue specificity. Predominantly expressed in brain, the strongest expression is seen in the frontal lobe, the subthalamic nucleus and the thalamus.
Post-translational modifications. Phosphorylated during hypoxia by ERK1/ERK2. Phosphorylation regulates the heme pocket hexacoordination preventing the association of His-64 with the heme metal center. Thereby, promotes the access of dioxygen and nitrite to the heme and stimulates the nitrite reductase activity. Phosphorylation during hypoxia is stabilized by 14-3-3 proteins. An intramolecular Cys-46/Cys-55 disulfide bond, not necessarily present in orthologs, regulates the heme pocket hexacoordination preventing the association of His-64 with the heme metal center. Thereby, promotes the access of dioxygen and nitrite to the heme and stimulates the nitrite reductase activity.
Similarity. Belongs to the globin family.
RefSeq proteins (1): NP_067080* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000971 | Globin | Domain |
| IPR009050 | Globin-like_sf | Homologous_superfamily |
| IPR012292 | Globin/Proto | Homologous_superfamily |
| IPR050532 | Globin-like_OT | Family |
Pfam: PF00042
Catalyzed reactions (Rhea), 1 shown:
- Fe(III)-heme b-[protein] + nitric oxide + H2O = Fe(II)-heme b-[protein] + nitrite + 2 H(+) (RHEA:77711)
UniProt features (25 total): helix 11, mutagenesis site 8, binding site 2, chain 1, domain 1, turn 1, disulfide bond 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7VQG | X-RAY DIFFRACTION | 1.35 |
| 8WUB | X-RAY DIFFRACTION | 1.5 |
| 4MPM | X-RAY DIFFRACTION | 1.74 |
| 1OJ6 | X-RAY DIFFRACTION | 1.95 |
| 8GRZ | X-RAY DIFFRACTION | 2 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NPG2-F1 | 95.09 | 0.92 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Ligand- & substrate-binding residues (2): 64 (distal binding residue; reversible); 96 (proximal binding residue)
Disulfide bonds (1): 46–55
Mutagenesis-validated functional residues (8):
| Position | Phenotype |
|---|---|
| 55 | loss of intramolecular disulfide bond. |
| 64 | increased nitrite reductase activity. |
| 120 | no effect on disulfide bond. |
| 17 | no effect on interaction with 14-3-3 proteins. |
| 46 | decreased nitrite reductase activity. |
| 46 | loss of intramolecular disulfide bond. |
| 50 | decreased interaction with 14-3-3 proteins. |
| 55 | decreased affinity for nitrite. decreased nitrite reductase activity. |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8981607 | Intracellular oxygen transport |
MSigDB gene sets: 55 (showing top):
chr14q24, GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS, AML_Q6, GOBP_RESPONSE_TO_OXYGEN_LEVELS, GOBP_GAS_TRANSPORT, GOBP_OXYGEN_TRANSPORT, GOBP_RESPONSE_TO_ABIOTIC_STIMULUS, AML1_01, DANG_BOUND_BY_MYC, GOMF_OXYGEN_BINDING, GOCC_MITOCHONDRIAL_MATRIX, BENPORATH_MYC_MAX_TARGETS, GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY
GO Biological Process (3): response to hypoxia (GO:0001666), oxygen transport (GO:0015671), cellular response to hypoxia (GO:0071456)
GO Molecular Function (8): GDP-dissociation inhibitor activity (GO:0005092), oxygen carrier activity (GO:0005344), oxygen binding (GO:0019825), heme binding (GO:0020037), metal ion binding (GO:0046872), nitrite reductase activity (GO:0098809), protein binding (GO:0005515), oxidoreductase activity (GO:0016491)
GO Cellular Component (4): mitochondrial matrix (GO:0005759), cytosol (GO:0005829), cytoplasm (GO:0005737), mitochondrion (GO:0005739)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Transport of small molecules | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 2 |
| cellular anatomical structure | 2 |
| response to stress | 1 |
| response to decreased oxygen levels | 1 |
| gas transport | 1 |
| response to hypoxia | 1 |
| cellular response to stress | 1 |
| cellular response to decreased oxygen levels | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| oxygen transport | 1 |
| oxygen binding | 1 |
| molecular carrier activity | 1 |
| small molecule binding | 1 |
| tetrapyrrole binding | 1 |
| cation binding | 1 |
| oxidoreductase activity, acting on other nitrogenous compounds as donors | 1 |
| binding | 1 |
| catalytic activity | 1 |
| mitochondrion | 1 |
| intracellular organelle lumen | 1 |
| intracellular anatomical structure | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
2034 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NGB | CYGB | Q8WWM9 | 975 |
| NGB | MB | P02144 | 964 |
| NGB | CYCS | P00001 | 939 |
| NGB | ADGB | Q8N7X0 | 846 |
| NGB | FLOT1 | O75955 | 773 |
| NGB | RHOA | P06749 | 636 |
| NGB | CYB5B | O43169 | 633 |
| NGB | CYB5A | P00167 | 632 |
| NGB | IDE | P14735 | 619 |
| NGB | GBE1 | Q04446 | 608 |
| NGB | HBB | P02023 | 543 |
| NGB | HIF1A | Q16665 | 541 |
| NGB | AHSP | Q9NZD4 | 540 |
| NGB | APOE | P02649 | 491 |
| NGB | GPX5 | O75715 | 489 |
| NGB | GPX2 | P18283 | 489 |
IntAct
59 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| NGB | TDO2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| VAC14 | NGB | psi-mi:“MI:0915”(physical association) | 0.720 |
| NGB | IHO1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TDO2 | NGB | psi-mi:“MI:0915”(physical association) | 0.720 |
| NGB | VAC14 | psi-mi:“MI:0915”(physical association) | 0.720 |
| IHO1 | NGB | psi-mi:“MI:0915”(physical association) | 0.720 |
| NGB | REL | psi-mi:“MI:0915”(physical association) | 0.560 |
| NGB | C1orf94 | psi-mi:“MI:0915”(physical association) | 0.560 |
| NGB | L3MBTL3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REL | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| L3MBTL3 | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| NGB | MEI4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GATAD2B | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| NIF3L1 | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| BTBD2 | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| DDIT4L | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEI4 | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| TEPSIN | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF655 | NGB | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (169): NGB (Two-hybrid), NGB (Two-hybrid), NGB (Two-hybrid), L3MBTL3 (Two-hybrid), C1orf94 (Two-hybrid), CCDC36 (Two-hybrid), AKT1 (FRET), NGB (Reconstituted Complex), NGB (Reconstituted Complex), MPP2 (Affinity Capture-MS), TRIM32 (Affinity Capture-MS), CCNB1 (Affinity Capture-MS), NGB (Reconstituted Complex), GNAO1 (Reconstituted Complex), NGB (Synthetic Lethality)
ESM2 similar proteins: A4FV98, A5D7B1, A6NFX1, D3ZVU9, O00764, O08557, O35083, O43488, O46560, O73884, O94760, O95848, P82197, Q05B60, Q0II59, Q0P5C0, Q0P5M9, Q0VD18, Q14728, Q29081, Q3KN66, Q3KRA9, Q3U129, Q3UGX3, Q3ZBF0, Q4PS77, Q5I0D5, Q5SUV1, Q64380, Q67FW5, Q6GV29, Q6WZ20, Q8CIW5, Q8K2U2, Q8R2H9, Q8TCT1, Q8VCE6, Q95JH0, Q95JH2, Q96AZ1
Diamond homologs: A0A072TK64, I3SX86, O66586, P02239, P02240, P04252, P23244, P24232, P26353, P39662, P39676, P40609, P49852, Q3KN66, Q47266, Q54D73, Q57LF5, Q59MV9, Q5PIH6, Q6D245, Q6EV97, Q6HLA6, Q6LM37, Q6WZ17, Q6WZ18, Q6WZ19, Q6WZ20, Q73B49, Q7ABK6, Q7C0F9, Q7MH09, Q7N215, Q7NSD8, Q7TTP0, Q7TTP2, Q7UIY1, Q7WHW5, Q7WUM8, Q81FW4, Q81T23
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 20 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
975 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:77268504:T:TA | donor_gain | 1.0000 |
| 14:77269209:TCTCA:T | donor_loss | 1.0000 |
| 14:77269210:CTCAC:C | donor_loss | 1.0000 |
| 14:77269211:TCAC:T | donor_loss | 1.0000 |
| 14:77269212:CA:C | donor_loss | 1.0000 |
| 14:77269213:ACCTT:A | donor_gain | 1.0000 |
| 14:77269214:CCT:C | donor_loss | 1.0000 |
| 14:77269214:CCTTC:C | donor_gain | 1.0000 |
| 14:77269217:T:A | donor_gain | 1.0000 |
| 14:77269323:CAGC:C | acceptor_gain | 1.0000 |
| 14:77270843:CCTCA:C | donor_loss | 1.0000 |
| 14:77270844:CTCA:C | donor_loss | 1.0000 |
| 14:77270845:TCAC:T | donor_loss | 1.0000 |
| 14:77270846:CAC:C | donor_loss | 1.0000 |
| 14:77266667:CTGT:C | acceptor_gain | 0.9900 |
| 14:77268491:A:AC | donor_gain | 0.9900 |
| 14:77268492:C:CC | donor_gain | 0.9900 |
| 14:77268582:TCAC:T | acceptor_gain | 0.9900 |
| 14:77268583:CAC:C | acceptor_gain | 0.9900 |
| 14:77268583:CACC:C | acceptor_gain | 0.9900 |
| 14:77268586:C:CC | acceptor_gain | 0.9900 |
| 14:77268590:C:CT | acceptor_gain | 0.9900 |
| 14:77269325:GC:G | acceptor_gain | 0.9900 |
| 14:77269326:CC:C | acceptor_gain | 0.9900 |
| 14:77269327:C:CC | acceptor_gain | 0.9900 |
| 14:77269328:T:A | acceptor_loss | 0.9900 |
| 14:77270848:CCTGG:C | donor_gain | 0.9900 |
| 14:77266538:A:AC | donor_gain | 0.9800 |
| 14:77266539:C:CC | donor_gain | 0.9800 |
| 14:77268457:TTTAC:T | donor_loss | 0.9800 |
AlphaMissense
971 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:77269290:G:C | F42L | 0.997 |
| 14:77269290:G:T | F42L | 0.997 |
| 14:77269292:A:G | F42L | 0.997 |
| 14:77266595:A:G | W133R | 0.996 |
| 14:77266595:A:T | W133R | 0.996 |
| 14:77268509:C:T | G93D | 0.996 |
| 14:77268501:G:C | H96D | 0.995 |
| 14:77269291:A:G | F42S | 0.995 |
| 14:77270854:A:C | F28L | 0.995 |
| 14:77270854:A:T | F28L | 0.995 |
| 14:77270856:A:G | F28L | 0.995 |
| 14:77266593:C:A | W133C | 0.994 |
| 14:77266593:C:G | W133C | 0.994 |
| 14:77269234:A:G | F61S | 0.994 |
| 14:77268509:C:A | G93V | 0.993 |
| 14:77270867:C:T | G24D | 0.993 |
| 14:77266654:A:G | L113P | 0.992 |
| 14:77268501:G:T | H96N | 0.992 |
| 14:77269224:G:C | H64Q | 0.992 |
| 14:77269224:G:T | H64Q | 0.992 |
| 14:77270868:C:G | G24R | 0.992 |
| 14:77266657:G:A | S112F | 0.991 |
| 14:77268510:C:G | G93R | 0.991 |
| 14:77268563:G:T | A75E | 0.991 |
| 14:77269226:G:C | H64D | 0.991 |
| 14:77269291:A:C | F42C | 0.991 |
| 14:77268469:G:C | F106L | 0.990 |
| 14:77268469:G:T | F106L | 0.990 |
| 14:77268471:A:G | F106L | 0.990 |
| 14:77268499:G:C | H96Q | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000009936 (14:77267347 C>A,G), RS1000055334 (14:77269720 C>G,T), RS1000841511 (14:77271210 C>A), RS1001299686 (14:77271651 C>CG), RS1001417178 (14:77265797 C>T), RS1001482008 (14:77265637 C>T), RS1002068340 (14:77268936 T>A,G), RS1002455198 (14:77267155 A>G), RS1002568109 (14:77265017 C>T), RS1002893275 (14:77266821 A>G), RS1002924588 (14:77265357 C>A), RS1003356407 (14:77269898 T>C), RS1003629551 (14:77269756 T>C), RS1004300500 (14:77273134 T>C), RS1004682293 (14:77269065 C>G)
Disease associations
OMIM: gene MIM:605304 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
22 total (human), top 22 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation, affects methylation, increases expression | 2 |
| bisphenol A | decreases methylation | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| MC1568 | affects binding, decreases reaction, decreases expression, increases expression | 1 |
| Calcium | affects transport | 1 |
| Chlorine | affects abundance | 1 |
| Copper | decreases uptake | 1 |
| Diethylhexyl Phthalate | affects binding, decreases reaction, decreases expression | 1 |
| Iron | decreases uptake | 1 |
| Lead | affects expression | 1 |
| Ozone | increases expression | 1 |
| Paraquat | increases abundance, decreases reaction, increases response to substance | 1 |
| Potassium | affects abundance | 1 |
| Rotenone | decreases expression | 1 |
| Sulfur | affects abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Zinc | decreases uptake | 1 |
| 1-Methyl-4-phenylpyridinium | decreases expression | 1 |
| Reactive Oxygen Species | increases response to substance, decreases reaction, increases abundance | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C0U0 | SH-SY5Y-FLAG-NGB | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.